252 related articles for article (PubMed ID: 14522728)
1. Randomized controlled crossover study of the effect of a highly beta-glucan-enriched barley on cardiovascular disease risk factors in mildly hypercholesterolemic men.
Keogh GF; Cooper GJ; Mulvey TB; McArdle BH; Coles GD; Monro JA; Poppitt SD
Am J Clin Nutr; 2003 Oct; 78(4):711-8. PubMed ID: 14522728
[TBL] [Abstract][Full Text] [Related]
2. High-Molecular-Weight β-Glucan Decreases Serum Cholesterol Differentially Based on the CYP7A1 rs3808607 Polymorphism in Mildly Hypercholesterolemic Adults.
Wang Y; Harding SV; Eck P; Thandapilly SJ; Gamel TH; Abdel-Aal el-SM; Crow GH; Tosh SM; Jones PJ; Ames NP
J Nutr; 2016 Apr; 146(4):720-7. PubMed ID: 26936139
[TBL] [Abstract][Full Text] [Related]
3. Effect of consuming novel foods consisting high oleic canola oil, barley β-glucan, and DHA on cardiovascular disease risk in humans: the CONFIDENCE (Canola Oil and Fibre with DHA Enhanced) study - protocol for a randomized controlled trial.
Ramprasath VR; Thandapilly SJ; Yang S; Abraham A; Jones PJ; Ames N
Trials; 2015 Oct; 16():489. PubMed ID: 26518870
[TBL] [Abstract][Full Text] [Related]
4. Beta-glucan- or rice bran-enriched foods: a comparative crossover clinical trial on lipidic pattern in mildly hypercholesterolemic men.
Rondanelli M; Opizzi A; Monteferrario F; Klersy C; Cazzola R; Cestaro B
Eur J Clin Nutr; 2011 Jul; 65(7):864-71. PubMed ID: 21505506
[TBL] [Abstract][Full Text] [Related]
5. Physiological effects of concentrated barley beta-glucan in mildly hypercholesterolemic adults.
Smith KN; Queenan KM; Thomas W; Fulcher RG; Slavin JL
J Am Coll Nutr; 2008 Jun; 27(3):434-40. PubMed ID: 18838533
[TBL] [Abstract][Full Text] [Related]
6. Quantitative assessment of the effects of beta-glucan consumption on serum lipid profile and glucose level in hypercholesterolemic subjects.
Zhu X; Sun X; Wang M; Zhang C; Cao Y; Mo G; Liang J; Zhu S
Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):714-23. PubMed ID: 26026211
[TBL] [Abstract][Full Text] [Related]
7. Cholesterol-lowering effect of beta-glucan from oat bran in mildly hypercholesterolemic subjects may decrease when beta-glucan is incorporated into bread and cookies.
Kerckhoffs DA; Hornstra G; Mensink RP
Am J Clin Nutr; 2003 Aug; 78(2):221-7. PubMed ID: 12885701
[TBL] [Abstract][Full Text] [Related]
8. Diets containing barley significantly reduce lipids in mildly hypercholesterolemic men and women.
Behall KM; Scholfield DJ; Hallfrisch J
Am J Clin Nutr; 2004 Nov; 80(5):1185-93. PubMed ID: 15531664
[TBL] [Abstract][Full Text] [Related]
9. Extracted oat and barley β-glucans do not affect cholesterol metabolism in young healthy adults.
Ibrügger S; Kristensen M; Poulsen MW; Mikkelsen MS; Ejsing J; Jespersen BM; Dragsted LO; Engelsen SB; Bügel S
J Nutr; 2013 Oct; 143(10):1579-85. PubMed ID: 23946347
[TBL] [Abstract][Full Text] [Related]
10. Serum lipids and postprandial glucose and insulin levels in hyperlipidemic subjects after consumption of an oat beta-glucan-containing ready meal.
Biörklund M; Holm J; Onning G
Ann Nutr Metab; 2008; 52(2):83-90. PubMed ID: 18334815
[TBL] [Abstract][Full Text] [Related]
11. [Effects of beta glucan in highland barley on blood glucose and serum lipid in high fat-induced C57 mouse].
Tian MJ; Song JN; Liu PP; Su LH; Sun CH; Li Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Jan; 47(1):55-8. PubMed ID: 23601524
[TBL] [Abstract][Full Text] [Related]
12. An Oat β-Glucan Beverage Reduces LDL Cholesterol and Cardiovascular Disease Risk in Men and Women with Borderline High Cholesterol: A Double-Blind, Randomized, Controlled Clinical Trial.
Ms Wolever T; Rahn M; Dioum E; Spruill SE; Ezatagha A; Campbell JE; Jenkins AL; Chu Y
J Nutr; 2021 Sep; 151(9):2655-2666. PubMed ID: 34236436
[TBL] [Abstract][Full Text] [Related]
13. The effect of oat β-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials.
Ho HV; Sievenpiper JL; Zurbau A; Blanco Mejia S; Jovanovski E; Au-Yeung F; Jenkins AL; Vuksan V
Br J Nutr; 2016 Oct; 116(8):1369-1382. PubMed ID: 27724985
[TBL] [Abstract][Full Text] [Related]
14. A systematic review and meta-analysis of randomized controlled trials of the effect of barley β-glucan on LDL-C, non-HDL-C and apoB for cardiovascular disease risk reduction
Ho HV; Sievenpiper JL; Zurbau A; Blanco Mejia S; Jovanovski E; Au-Yeung F; Jenkins AL; Vuksan V
Eur J Clin Nutr; 2016 Nov; 70(11):1239-1245. PubMed ID: 27273067
[TBL] [Abstract][Full Text] [Related]
15. Effect of 6 weeks' consumption of β-glucan-rich oat products on cholesterol levels in mildly hypercholesterolaemic overweight adults.
Charlton KE; Tapsell LC; Batterham MJ; O'Shea J; Thorne R; Beck E; Tosh SM
Br J Nutr; 2012 Apr; 107(7):1037-47. PubMed ID: 21810288
[TBL] [Abstract][Full Text] [Related]
16. Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial.
Queenan KM; Stewart ML; Smith KN; Thomas W; Fulcher RG; Slavin JL
Nutr J; 2007 Mar; 6():6. PubMed ID: 17386092
[TBL] [Abstract][Full Text] [Related]
17. Barley and wheat foods: influence on plasma cholesterol concentrations in hypercholesterolemic men.
McIntosh GH; Whyte J; McArthur R; Nestel PJ
Am J Clin Nutr; 1991 May; 53(5):1205-9. PubMed ID: 1850576
[TBL] [Abstract][Full Text] [Related]
18. Beta-glucan fractions from barley and oats are similarly antiatherogenic in hypercholesterolemic Syrian golden hamsters.
Delaney B; Nicolosi RJ; Wilson TA; Carlson T; Frazer S; Zheng GH; Hess R; Ostergren K; Haworth J; Knutson N
J Nutr; 2003 Feb; 133(2):468-75. PubMed ID: 12566485
[TBL] [Abstract][Full Text] [Related]
19. Supplementation of a high-carbohydrate breakfast with barley beta-glucan improves postprandial glycaemic response for meals but not beverages.
Poppitt SD; van Drunen JD; McGill AT; Mulvey TB; Leahy FE
Asia Pac J Clin Nutr; 2007; 16(1):16-24. PubMed ID: 17215176
[TBL] [Abstract][Full Text] [Related]
20. Supplementation with a β-glucan tablet has no effect on hyperlipidemia: a randomized, placebo-controlled clinical trial.
Rioux-Labrecque V; Cossette M; Rufiange M; Bilodeau D; Guertin MC; Tardif JC
Am J Clin Nutr; 2023 Jun; 117(6):1232-1239. PubMed ID: 37054888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
